Trustcore Financial Services LLC Invests $356,000 in Stryker Co. (SYK)

Trustcore Financial Services LLC bought a new stake in shares of Stryker Co. (NYSE:SYK) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 1,801 shares of the medical technology company’s stock, valued at approximately $356,000.

Other large investors also recently bought and sold shares of the company. Oregon Public Employees Retirement Fund boosted its position in shares of Stryker by 8,029.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,075,473 shares of the medical technology company’s stock worth $39,000 after buying an additional 6,000,739 shares during the period. Norges Bank acquired a new position in shares of Stryker during the fourth quarter worth approximately $474,132,000. BlackRock Inc. boosted its position in shares of Stryker by 4.1% during the fourth quarter. BlackRock Inc. now owns 24,882,912 shares of the medical technology company’s stock worth $3,900,399,000 after buying an additional 975,678 shares during the period. GQG Partners LLC acquired a new position in shares of Stryker during the fourth quarter worth approximately $116,175,000. Finally, Ellis Investment Partners LLC boosted its position in shares of Stryker by 19,658.9% during the first quarter. Ellis Investment Partners LLC now owns 367,318 shares of the medical technology company’s stock worth $367,000 after buying an additional 365,459 shares during the period. 74.71% of the stock is owned by institutional investors.

Several equities analysts have recently issued reports on the company. Canaccord Genuity boosted their price objective on Stryker from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Zacks Investment Research upgraded Stryker from a “hold” rating to a “buy” rating and set a $199.00 target price for the company in a research report on Monday, February 4th. Deutsche Bank upped their target price on Stryker from $181.00 to $208.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. ValuEngine upgraded Stryker from a “hold” rating to a “buy” rating in a research report on Friday, May 3rd. Finally, Royal Bank of Canada upped their target price on Stryker from $184.00 to $204.00 and gave the stock an “outperform” rating in a research report on Monday, March 11th. Six research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Stryker currently has an average rating of “Buy” and a consensus price target of $196.85.

In related news, insider Timothy J. Scannell sold 4,666 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $186.71, for a total value of $871,188.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Kevin Lobo sold 41,750 shares of the company’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $194.11, for a total transaction of $8,104,092.50. The disclosure for this sale can be found here. Insiders sold 116,216 shares of company stock worth $22,245,359 over the last ninety days. 7.20% of the stock is currently owned by company insiders.

Shares of NYSE:SYK opened at $184.14 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.30 and a current ratio of 2.12. Stryker Co. has a 12-month low of $144.75 and a 12-month high of $199.85. The firm has a market cap of $68.70 billion, a price-to-earnings ratio of 25.19, a PEG ratio of 2.24 and a beta of 0.84.

Stryker (NYSE:SYK) last announced its earnings results on Tuesday, April 23rd. The medical technology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Stryker had a net margin of 25.38% and a return on equity of 26.72%. The company had revenue of $3.52 billion for the quarter, compared to the consensus estimate of $3.51 billion. During the same period in the previous year, the business earned $1.68 EPS. The company’s revenue was up 8.5% on a year-over-year basis. On average, sell-side analysts forecast that Stryker Co. will post 8.15 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend is Thursday, June 27th. Stryker’s dividend payout ratio (DPR) is presently 28.45%.

COPYRIGHT VIOLATION NOTICE: “Trustcore Financial Services LLC Invests $356,000 in Stryker Co. (SYK)” was first reported by WKRB News and is the property of of WKRB News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.wkrb13.com/2019/05/19/trustcore-financial-services-llc-invests-356000-in-stryker-co-syk.html.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Read More: How is an ETF different from a mutual fund?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.